This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovations of Volkmar Herrmann
Introduction
Volkmar Herrmann is a notable inventor based in Sandberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antithrombotic activity. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Herrmann holds a patent for "Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors." This patent relates to compounds of formula I, which exhibit antithrombotic activity by inhibiting the protease-activated receptor 1 (PAR1). The compounds are designed to be used as pharmaceutical products, showcasing Herrmann's commitment to advancing medical science.
Career Highlights
Volkmar Herrmann is associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to collaborate with other experts in the field, contributing to the development of innovative therapeutic solutions. His work has been instrumental in pushing the boundaries of pharmaceutical research.
Collaborations
Some of his notable coworkers include Karl Schoenafinger and Henning Steinhagen. Their collaboration has fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Volkmar Herrmann's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a key figure in medical research. His work continues to impact the development of effective treatments for various health conditions.
